On September 26, 2016, 37 organizations signed an open letter to Senate Majority Leader Mitch McConnell, urging McConnell to reject any poison pill language in budget legislation that would prohibit the Securities and Exchange Commission from strengthening corporate disclosure laws by requiring transparency of secret political spending.
On May 25, 2016, The Wall Street Journal reported that the FBI and the SEC are investigating Sen. Bob Corker (R-TN) for his lucrative stock trades of real estate investment giant CBL Associates Properties, a real estate company based in Chattanooga, Tennessee.
CfA Files SEC and Ethics Complaints Against Sen. Robert Corker (R-TN) for Concealing Lucrative Financial Holdings
On March 21, 2016, CfA filed a second complaint with the Securities and Exchange Commission and the Senate Select Committee on Ethics, alleging Sen. Robert Corker (R-TN) concealed information about his stake in several hedge funds – funds managed by his campaign donors – in violation of federal law and Senate rules.
Campaign for Accountability Requests SEC and Ethics Investigation of Sen. Robert Corker (R-TN) for Insider Trading
On November 10, 2015, CfA filed a complaint with the Securities and Exchange Commission and the Senate Select Committee on Ethics, alleging Sen. Robert Corker (R-TN) may have engaged in insider trading and made false statements on his personal financial disclosure forms in violation of federal law and Senate rules.
On October 1, 2015, CfA called on two congressional committees to investigate Martin Shkreli, the CEO of Turing Pharmaceuticals, for manipulating the Food and Drug Administration’s (FDA) regulatory process for his personal financial gain.